Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
47.76
+1.84 (4.01%)
At close: Feb 6, 2026

SHA:600329 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,0492,9442,1252,8832,2831,987
Short-Term Investments
685.281,00061.740.61109.64-
Cash & Short-Term Investments
1,7343,9452,1872,9232,3931,987
Cash Growth
15.81%80.37%-25.19%22.16%20.40%30.49%
Accounts Receivable
1,6241,3162,6532,7251,9711,971
Other Receivables
11.798.5634.160.7740.7336.63
Receivables
1,6361,3252,6872,7852,0112,007
Inventory
1,2051,2861,5671,4291,5251,488
Other Current Assets
2,39252.96111.07107.5495.77121.13
Total Current Assets
6,9676,6086,5527,2456,4255,604
Property, Plant & Equipment
1,2301,3931,4421,4651,4861,460
Long-Term Investments
1,1841,294882.67801.46740.74803.85
Goodwill
12.312.365.9184.69--
Other Intangible Assets
272.85295.29317.75281.13198.19202.51
Long-Term Deferred Tax Assets
319.35314.4265.99208.35154.6165.48
Long-Term Deferred Charges
62.4666.0718.317.544.728.81
Other Long-Term Assets
1,537785.43686.2953.7757.5139.47
Total Assets
11,58510,76910,23010,1579,0678,283
Accounts Payable
200.12284.511,1261,4061,242902.25
Accrued Expenses
268.831,7871,4931,170679.77709.16
Short-Term Debt
14.8821.6581.8101.64--
Current Portion of Long-Term Debt
----30-
Current Portion of Leases
1.741.333.564.11.61
Current Income Taxes Payable
123.05297.5776.6893.289.5310.49
Current Unearned Revenue
76.53123.14145.66219.07215.61246.67
Other Current Liabilities
1,791302.52305.66339.37254.89294.27
Total Current Liabilities
2,4772,8183,2333,3332,4342,164
Long-Term Debt
-10251.03161.31040
Long-Term Leases
3.935.62.740.871.571.71
Long-Term Unearned Revenue
41.3955.1457.1459.8859.1563.35
Long-Term Deferred Tax Liabilities
5.126.047.338.824.213.8
Other Long-Term Liabilities
34.0724.0733.6940.7344.4260.78
Total Liabilities
2,5612,9193,5853,6052,5532,333
Common Stock
770.09770.09770.16773.44773.44773.64
Additional Paid-In Capital
974.98974.79975.211,0481,3741,365
Retained Earnings
7,2386,0724,8284,7004,2183,681
Treasury Stock
---7.04-29.75-32.03-34.78
Comprehensive Income & Other
26.0326.9334.3429.5330.6223.19
Total Common Equity
9,0097,8446,6016,5216,3645,808
Minority Interest
14.756.3444.5530.49149.35141.49
Shareholders' Equity
9,0247,8506,6456,5526,5145,950
Total Liabilities & Equity
11,58510,76910,23010,1579,0678,283
Total Debt
20.5538.59339.14267.9143.1742.71
Net Cash (Debt)
1,7133,9061,8482,6552,3501,945
Net Cash Growth
698.51%111.39%-30.41%13.01%20.83%31.46%
Net Cash Per Share
2.235.062.403.423.052.53
Filing Date Shares Outstanding
770.09770.09770.16773.44773.44773.64
Total Common Shares Outstanding
770.09770.09770.16773.44773.44773.64
Working Capital
4,4903,7903,3193,9123,9913,440
Book Value Per Share
11.7010.198.578.438.237.51
Tangible Book Value
8,7247,5366,2176,1566,1665,606
Tangible Book Value Per Share
11.339.798.077.967.977.25
Buildings
-1,3251,3381,3371,3231,341
Machinery
-1,0661,1071,0871,028978.12
Construction In Progress
-436.35386.46333.85331.62285.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.